Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L Rassenti

Rituximab in Combination With High-Dose Methylprednisolone for the Treatment of Chronic Lymphocytic Leukemia

Cancer Research

English

Related publications

Five Years of Experience With Rituximab Plus High-Dose Dexamethasone for Relapsed/Refractory Chronic Lymphocytic Leukemia

Archives of Medical Science

English

Comparative Efficacy of Chronic Lymphocytic Leukemia Treatment With or Without Rituximab

Oncogematologiya

English

Rituximab–cyclophosphamide–dexamethasone Combination in the Management of Autoimmune Cytopenias Associated With Chronic Lymphocytic Leukemia

Cancer Research

English

Cost-Utility of Idelalisib in Combination With Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Value in Health

Occupational Health

English

A Breakthrough Therapy in Relapsed Chronic Lymphocytic Leukemia: The Combination of Idelalisib and Rituximab

Postdoc journal

English

Idelalisib for the Treatment of Chronic Lymphocytic Leukemia

English

Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine

Cancer Management and Research

English

High-Dose Intravenous Methylprednisolone for the Prophylactic Treatment of Cluster Headache

Multidisciplinary

English

A Phase I/Ii Study of Rituximab and Etanercept in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Cancer Research

English